CONJUCHEM Canadian Trademark Information
pharmaceutical preparations for the treatment of diabetes and other disorders of the metabolic system, namely disorders that involve an alteration in the normal metabolism of carbohydrates, lipids, proteins, water, salts, and/or nucleic acids , pharmaceutical preparations for the treatment of obesity, HIV infection, growth hormone disorders, lipodystrophy, sarcopenia, cardiovascular disorders, intestinal diseases, pain, and cancer Research and development in the field drug delivery systems, namely vehicles or carriers designed to transport and deliver drugs to a required site on or within the body and designed to control the release of the drug depending on the nature of the carrier; research and development of a platform technology which extends the half life of peptides and small molecules by covalently bonding the peptide or small molecule to a specific site on a blood serum protein, principally albumin, through the use of reactive chemistry groups; research and development of new pharmaceutical products
Perfect for these industries
Words that describe this mark
pharmaceutical preparations treatment diabetes disorders metabolic disorders involve alteration normal metabolism carbohydrates lipids proteins water salts andor nucleic acids pharmaceutical preparations treatment obesity hiv infection growth
Abandonment Notice!
On Wednesday, September 12, 2012,
status on the CONJUCHEM
trademark changed to Interruption of proceeding.
Apply Now for this name starting at $449!
CAUTION: Although Canada registration for this particular filing is inactive,
the mark may still enjoy common law rights, or may have been applied for again in a separate application.
Further research may be warranted to determine where this mark is truly abandoned in commerce.
On Friday, August 22, 2008, a canadian trademark registration was filed for
CONJUCHEM by ConjuChem Biotechnologies Inc. *********, **********, ***** ****.
The Canadian IP office has given the trademark application number of
1408388.
The current status of this trademark filing is Interruption of proceeding.
The correspondent listed for
CONJUCHEM is
BERESKIN & PARR LLP/S.E.N.C.R. of *********, **********, ***** ****
The CONJUCHEM
trademark is filed in the description of
pharmaceutical preparations for the treatment of diabetes and other disorders of the metabolic system, namely disorders that involve an alteration in the normal metabolism of carbohydrates, lipids, proteins, water, salts, and/or nucleic acids , pharmaceutical preparations for the treatment of obesity, HIV infection, growth hormone disorders, lipodystrophy, sarcopenia, cardiovascular disorders, intestinal diseases, pain, and cancer
,
Research and development in the field drug delivery systems, namely vehicles or carriers designed to transport and deliver drugs to a required site on or within the body and designed to control the release of the drug depending on the nature of the carrier; research and development of a platform technology which extends the half life of peptides and small molecules by covalently bonding the peptide or small molecule to a specific site on a blood serum protein, principally albumin, through the use of reactive chemistry groups; research and development of new pharmaceutical products
.
100% Satisfaction Guarantee
protect your valuable brand now.
Classification Information
Trademarkia is the largest search engine for U.S., China, European Union, Canada, and Australia Trademarks.
Each month hundreds of trademarks around the world are filed by licensed attorneys in the Trademarkia network law firms!
You can
register your trademark in 180+ countries
in the world through Trademarkia Network. Trademarkia.com is a free search engine of publicly available government records.
Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.